The centromere-kinetochore complex (CKC) mediates high fidelity chromosomal segregation, owing to both its mechanical and regulatory roles in orchestrating mitosis. It safeguards against aneuploidy associated with tumorigenesis, miscarriages, and congenital disorders. The pathway of molecular interactions leading to CKC assembly on human chromosomes remains largely unknown. The long range objectives of this project are to elucidate CKC specification, assembly, and function in a model organism, S. cerevisiae, using the yeast homologs of human CENP-A and CENP-C-Cse4p and Mif2p-as focal points.
The specific aims are: 1. To elucidate budding yeast CKC assembly and architecture in vivo. a) Yeast centromere protein-CEN DNA interactions, as defined by in vivo crosslinking and immunoprecipitation (ChIP), will be assessed in mutants defective for cis- or trans-acting centromere components and in synchronized cells to generate a genetic and temporal blueprint for centromere assembly. b) ChIP will also be used to test whether yeast mitotic checkpoint pathway proteins, components of a signaling pathway that responds to centromere defects, are present at CKCs. 2. To develop additional assays for structural analysis of CKCs assembled in vivo. a) UV crosslinking will be used to characterize direct centromere protein-CEN DNA interactions. b) A CEN DNA-based one-hybrid system will be developed to study centromere protein-CEN DNA interactions in vivo independently of crosslinking. 3. To define the intrinsic and extrinsic determinants of Cse4p and Mif2p CKC targeting. a) Cse4p and Mif2p interaction with other yeast CKC proteins will be tested using a two-hybrid approach. b) Deletion analysis will be used to map domains required for two-hybrid interactions and centromere targeting as determined by ChIP. 4. To characterize the function of the CENP-C-related centromere protein, Mif2p. a) mif2 mutants will be tested for centromere-specific defects using genetic, cytological and biochemical assays. b) In vitro translated or recombinant Mif2p will be tested for in vitro DNA and MT binding. And c) proteins that interact with Mif2p will be identified using two-hybrid and genetic approaches. 5. To use Cse4p as a cytological marker for yeast centromere position. Cse4p localization will be characterized using indirect immunofluorescence, GFP fluorescence, and immuno-EM in wildtype and mutant cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM060464-04
Application #
6628849
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Deatherage, James F
Project Start
2000-02-01
Project End
2005-01-31
Budget Start
2003-02-01
Budget End
2004-01-31
Support Year
4
Fiscal Year
2003
Total Cost
$249,763
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Nathan, Dafna; Ingvarsdottir, Kristin; Sterner, David E et al. (2006) Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev 20:966-76
Stead, Kristen; Aguilar, Cristina; Hartman, Theresa et al. (2003) Pds5p regulates the maintenance of sister chromatid cohesion and is sumoylated to promote the dissolution of cohesion. J Cell Biol 163:729-41
Enquist-Newman, M; Cheeseman, I M; Van Goor, D et al. (2001) Dad1p, third component of the Duo1p/Dam1p complex involved in kinetochore function and mitotic spindle integrity. Mol Biol Cell 12:2601-13